BUY Alivus Life Sciences — Siddharth Rai Mangala, 09 Sept 2026

bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))9 Sept 2026via Zee Business (Live)

Entry₹1,416.6Inferred

Target₹1,530

Stop loss₹1,375-2.94% risk

CMP₹1,400.116h ago

Active-1.16%+9.28%upside left 13d left

Follow Siddharth Rai Mangala for new calls(33% target hit, 101 closed calls)Get alerts Watch ALIVUS for new buy/sell callsGet alerts See 273 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 10 Sept, 8:22 am IST

2 supporting2 opposing

Supports the BUY call (2)

Alivus Life Sciences passes ₹5 dividend, approves FY26 results at AGM

NewsGoogle News·8 Sept · yesterday

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·30 Jun · 2mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·10 Sept · today

Alivus Life Sciences Slips 1.79%: Stock Hovers Near Key Support Zone - Combination Correction

NewsGoogle News·3 Sept · 1w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Alivus Life Sciences Limited — Siddharth Rai Mangala

AI Assessment